Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Zuurbier SM, Hickman CR, Tolias CS, et al; Scottish Audit of Intracranial Vascular Malformations Steering Committee. Lancet Neurol 2019; 18:935-941. Abstract BACKGROUND: Antithrombotic (anticoagulant or antiplatelet) therapy is withheld from some patients with cerebral cavernous […]

via Are antiplatelets and anticoagulants safe and beneficial in people with cavernomas? — Neurochecklists Blog

4 thoughts on “Are antiplatelets and anticoagulants safe and beneficial in people with cavernomas?

  1. I have been taking coumadin for over 20 years because of genetic hyperhomocystinemia. I have recently developed a cerebral cavernoma and would like to know if continued use of coumadin is indicated, or if surgical removal of cavernoma is a better choice.

    Like

    1. Thanks for your comments Linda. It is difficult to advise on individual cases but you may consider that the risk of significant bleeding from a cavernoma is relatively less than the risk of thrombosis from hyperhomocystinemia. In general, most cavernomas are best left alone unless they are causing significant symptoms. You may consider discussing the use of the newer oral anticoagulants with your specialist

      Like

      1. My sincere thanks to you for taking the time to reply to my “comment”. After experiencing a few small bleeds, any and all reassurances are very much appreciated. Thank you so very much !

        Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s